Loading clinical trials...
Loading clinical trials...
Darifenacin Versus Parasacral Transcutaneous Electric Nerve Stimulation for Overactive Bladder Syndrome in Patients Infected With Human T-Lymphotropic Virus 1 - Randomized Open Clinical Trial
Conditions
Interventions
Darifenacin
Neuromodulation - Sacral nerve stimulation
Locations
1
Brazil
Ambulatório de HTLV-1 - Com HUPES
Salvador, Estado de Bahia, Brazil
Start Date
March 16, 2022
Primary Completion Date
December 20, 2023
Completion Date
December 20, 2023
Last Updated
October 1, 2024
NCT04873037
NCT06198439
NCT06769854
NCT03535857
NCT05719285
NCT06123364
Lead Sponsor
Hospital Universitário Professor Edgard Santos
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions